Clinical Trial Update: A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating RNA-lipid particle vaccines for newly diagnosed pediatric high-grade gliomas and adult glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• RNA-lipid Particle Vaccine (RNA-LP)

Snippet

Sponsor: University of Florida | Conditions: Adult Glioblastoma, High Grade Glioma | Phase 1 | Status: RECRUITING